×
  • Select the area you would like to search.
  • ACTIVE INVESTIGATIONS Search for current projects using the investigator's name, institution, or keywords.
  • EXPERTS KNOWLEDGE BASE Enter keywords to search a list of questions and answers received and processed by the ADNI team.
  • ADNI PDFS Search any ADNI publication pdf by author, keyword, or PMID. Use an asterisk only to view all pdfs.
Principal Investigator  
Principal Investigator's Name: Xinhui Ma
Institution: University of Hull
Department: Computer Science
Country:
Proposed Analysis: The work aims to identify mild cognitive impairment (MCI) patients who have a high likelihood of developing Alzheimer's disease (AD) using novel deep learning methods. The deep learning method will combine structural magnetic resonance imaging (MRI), demographic, neuropsychological, and APOe4 genetic data as input measures. The deep learning methods will be based on dual learning and an ad hoc layer for 3D separable convolutions. The work will develop objective measures that are able to discriminate the MCI patients who are at risk of AD from those MCI patients who have less risk to develop AD, so that doctors can identify and choose effective and personalized strategies to prevent or slow the progression of AD.
Additional Investigators  
Investigator's Name: Emma Wolverson
Proposed Analysis: The work aims to identify mild cognitive impairment (MCI) patients who have a high likelihood of developing Alzheimer's disease (AD) using novel deep learning methods. The deep learning method will combine structural magnetic resonance imaging (MRI), demographic, neuropsychological, and APOe4 genetic data as input measures. The deep learning methods will be based on dual learning and an ad hoc layer for 3D separable convolutions. The work will develop objective measures that are able to discriminate the MCI patients who are at risk of AD from those MCI patients who have less risk to develop AD, so that doctors can identify and choose effective and personalized strategies to prevent or slow the progression of AD.